• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Increased risk of myelotoxicity in elderly patients with non-Hodgkin lymphoma.

作者信息

Balducci Lodovico, Repetto Lazzaro

机构信息

Senior Adult Oncology Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida 33612, USA.

出版信息

Cancer. 2004 Jan 1;100(1):6-11. doi: 10.1002/cncr.11861.

DOI:10.1002/cncr.11861
PMID:14692018
Abstract
摘要

相似文献

1
Increased risk of myelotoxicity in elderly patients with non-Hodgkin lymphoma.
Cancer. 2004 Jan 1;100(1):6-11. doi: 10.1002/cncr.11861.
2
Risk models for chemotherapy-induced neutropenia in non-Hodgkin's lymphoma.非霍奇金淋巴瘤化疗引起中性粒细胞减少的风险模型
Oncology (Williston Park). 2003 Nov;17(11 Suppl 11):21-6.
3
Use of colony-stimulating factors for chemotherapy-associated neutropenia: review of current guidelines.集落刺激因子在化疗相关性中性粒细胞减少症中的应用：现行指南综述
Semin Hematol. 2007 Jul;44(3):148-56. doi: 10.1053/j.seminhematol.2007.04.002.
4
Incidence of febrile neutropenia and neutropenic infections in elderly patients receiving anthracycline-based chemotherapy for breast cancer without primary prophylaxis with colony-stimulating factors.在接受基于蒽环类药物的化疗且未进行集落刺激因子一级预防的老年乳腺癌患者中，发热性中性粒细胞减少症和中性粒细胞减少性感染的发生率。
Crit Rev Oncol Hematol. 2005 Feb;53(2):125-31. doi: 10.1016/j.critrevonc.2004.11.003.
5
Economic evaluation of prophylactic granulocyte colony stimulating factor during chemotherapy in elderly patients with aggressive non-Hodgkin's lymphoma.老年侵袭性非霍奇金淋巴瘤患者化疗期间预防性使用粒细胞集落刺激因子的经济学评估
Haematologica. 2004 Sep;89(9):1109-17.
6
Chemotherapy in the elderly: supportive measures for chemotherapy-induced myelotoxicity.老年患者的化疗：化疗所致骨髓毒性的支持性措施
Clin J Oncol Nurs. 2003 Mar-Apr;7(2):185-90. doi: 10.1188/03.CJON.185-190.
7
Treatment of therapy-related acute myeloid leukemia occurring in elderly non-Hodgkin lymphoma patients with low-dose cytarabine, aclarubicin and granulocyte colony-stimulating factor.低剂量阿糖胞苷、阿克拉霉素和粒细胞集落刺激因子治疗老年非霍奇金淋巴瘤患者发生的治疗相关急性髓系白血病
Leuk Res. 2009 Jan;33(1):197-200. doi: 10.1016/j.leukres.2008.04.002. Epub 2008 May 12.
8
Same day Pegfilgrastim and CHOP chemotherapy for non-Hodgkin lymphoma.非霍奇金淋巴瘤的同日培非格司亭与CHOP化疗
Am J Clin Oncol. 2006 Aug;29(4):361-3. doi: 10.1097/01.coc.0000217816.16236.22.
9
[VNCOP-B (etoposide, mitoxantrone, cyclophosphamide, vincristine, predonisolone, bleomycin) therapy in elderly patients with aggressive non-Hodgkin lymphoma--a study of efficacy and safety, final report].[依托泊苷、米托蒽醌、环磷酰胺、长春新碱、泼尼松龙、博来霉素（VNCOP - B）方案治疗老年侵袭性非霍奇金淋巴瘤——疗效与安全性研究，最终报告]
Gan To Kagaku Ryoho. 2005 Jan;32(1):39-44.
10
[The elderly patient with intermediate-grade and high-grade malignant non-Hodgkin lymphoma].[老年中高级别恶性非霍奇金淋巴瘤患者]
Ned Tijdschr Geneeskd. 1991 Aug 24;135(34):1534-8.

引用本文的文献

1
Pegteograstim prophylaxis for chemotherapy-induced neutropenia and febrile neutropenia: a prospective, observational, postmarketing surveillance study in Korea.培格司亭预防化疗引起的中性粒细胞减少和发热性中性粒细胞减少症：韩国一项前瞻性、观察性、上市后监测研究。
Support Care Cancer. 2021 Sep;29(9):5383-5390. doi: 10.1007/s00520-021-06127-7. Epub 2021 Mar 8.
2
Management of the toxicity of chemotherapy and targeted therapies in elderly cancer patients.老年癌症患者化疗和靶向治疗毒性的管理。
Clin Transl Oncol. 2020 Apr;22(4):457-467. doi: 10.1007/s12094-019-02167-y. Epub 2019 Jun 25.
3
Pegfilgrastim in primary prophylaxis of febrile neutropenia in elderly patients with hematological malignancies-bendamustine and G-CSF support.
聚乙二醇化重组人粒细胞刺激因子用于老年血液系统恶性肿瘤患者发热性中性粒细胞减少症的一级预防——苯达莫司汀与粒细胞集落刺激因子支持
Support Care Cancer. 2019 May;27(5):1587-1588. doi: 10.1007/s00520-019-4651-5. Epub 2019 Jan 23.
4
Can Vulnerable Elders Survey-13 predict the impact of frailty on chemotherapy in elderly patients with gynaecological malignancies?脆弱老年人调查-13能否预测虚弱对老年妇科恶性肿瘤患者化疗的影响？
Medicine (Baltimore). 2018 Sep;97(39):e12298. doi: 10.1097/MD.0000000000012298.
5
Management of aggressive lymphoma in very elderly patients.高龄侵袭性淋巴瘤的管理
Hematol Oncol. 2017 Jun;35 Suppl 1(Suppl Suppl 1):49-53. doi: 10.1002/hon.2413.
6
Outcomes of very elderly patients with aggressive B-cell non-Hodgkin lymphoma treated with reduced-dose chemotherapy.采用减量化疗治疗的高龄侵袭性B细胞非霍奇金淋巴瘤患者的治疗结果
Int J Clin Oncol. 2016 Jun;21(3):498-505. doi: 10.1007/s10147-015-0912-6. Epub 2015 Oct 13.
7
Management Strategies for Elderly Patients with Diffuse Large B-Cell Lymphoma.老年弥漫性大B细胞淋巴瘤患者的管理策略
Eur Oncol Haematol. 2012 May;8(2):123-126. doi: 10.17925/eoh.2012.08.02.123.
8
Anti-idiotype antibodies in cancer treatment: the pharmaceutical industry perspective.癌症治疗中的抗独特型抗体：制药行业视角。
Front Oncol. 2012 Oct 29;2:147. doi: 10.3389/fonc.2012.00147. eCollection 2012.
9
Senior adult oncology.老年肿瘤学
J Natl Compr Canc Netw. 2012 Feb;10(2):162-209. doi: 10.6004/jnccn.2012.0019.